Patients with systemic lupus erythematosus (SLE) have a circulating inducer of interferon-alpha (IFN-α) production acting on leucocytes resembling immature dendritic cells

Clinical and Experimental Immunology

Volumn 115, Issue 1, 1999, Pages 196-202

  Vallin, H ^a   Blomberg, S ^b   Alm, G V ^a   Cederblad, B ^a   Rönnblom, Lars ^b  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Dendritic cells; Interferon inducer; Interferon alpha; Systemic lupus erythematosus

Indexed keywords

ALPHA INTERFERON; AZATHIOPRINE; CYCLOHEXIMIDE; PREDNISOLONE; RECOMBINANT ALPHA2B INTERFERON; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DISEASE ACTIVITY; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTE; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGED; DENDRITIC CELLS; FEMALE; HUMANS; IN SITU HYBRIDIZATION; INTERFERON INDUCERS; INTERFERON-ALPHA; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RNA, MESSENGER; ULTRAFILTRATION;

EID: 0032950459     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00772.x     Document Type: Article

References (40)

1. 1 Wallace DJ, Hahn B. Dubois' lupus erythematosus, 5th edn. Baltimore: Williams and Wilkins, 1997.
2. 2 Kim T, Kanayama Y, Negoro N, Okamura M, Takeda T, Inoue T. Serum levels of interferons in patients with systemic lupus erythematosus. Clin Exp Immunol 1987; 70:562-9.
3. 3 Klippel JH, Carette S, Preble OT, Friedman RM, Grimley PM. Serum alpha interferon and lymphocyte inclusions in systemic lupus erythematosus. Ann Rheum Dis 1985; 44:104-8.
4. 4 Preble OT, Rothko K, Klippel JH, Friedman RM, Johnston MI. Interferon-induced 2′-5′ adenylate synthetase in vivo and interferon production in vitro by lymphocytes from systemic lupus erythematosus patients with and without circulating interferon. J Exp Med 1983; 157:2140-6.
5. 5 Strannegård Ö, Hermodsson S, Westberg G. Interferon and natural killer cells in systemic lupus erythematosus. Clin Exp Immunol 1982; 50:246-52.
6. 6 Ytterberg SR, Schnitzer TJ. Serum interferon levels in patients with systemic lupus erythematosus. Arthritis Rheum 1982; 25:401-6.
7. 7 von Wussow P, Jakschies D, Hartung K, Deicher H. Presence of interferon and anti-interferon in patients with systemic lupus erythematosus. Rheumatol Int 1988; 8:225-30.
8. 8 von Wussow P, Jakschies D, Hochkeppel H, Horisberger M, Hartung K, Deicher H. MX homologous protein in mononuclear cells from patients with systemic lupus erythematosus. Arthritis Rheum 1989; 32:914-8.
9. 9 Rönnblom LE, Alm GV, Öberg KE. Possible induction of systemic lupus erythematosus by interferon-α treatment in a patient with a malignant carcinoid tumour. J Intern Med 1990; 227:207-10.
10. 10 Rönnblom LE, Alm GV, Öberg KE. Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors. Ann Intern Med 1991; 115:178-83.
11. 11 Fritzler MJ. Drugs recently associated with lupus syndromes. Lupus 1994; 3:455-9.
12. 12 Belardelli F. Role of interferons and other cytokines in the regulation of the immune response. APMIS 1995; 103:161-79.
13. 13 D'Cunha J, Ramanujam S, Wagner RJ, Witt PL, Knight E Jr, Borden EC. In vitro and in vivo secretion of human ISG15, an IFN-induced immunomodulatory cytokine. J Immunol 1996; 157:4100-8.
14. 14 Rogge L, Barberis-Maino L, Biffi M et al. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J Exp Med 1997; 5:825-31.
15. 15 Gray D. Viral immunity: interferons jog old T-cell memories. Curr Biol 1996; 6:1254-5.
16. 16 Belardelli F, Gresser I. The neglected role of type I interferon in the T-cell response: implications for its clinical use. Immunol Today 1996; 17:369-71.
17. 17 Riffault S, Eloranta M-L, Carrat C, Sandberg K, Charley B, Alm G. Herpes simplex virus induced appearance of IFN-α/β producing cells and partially IFN-α/β dependent accumulation of leukocytes in murine regional lymph nodes. J Interferon Cytokine Res 1996; 16:1007-14.
18. 18 De Maeyer E, De Maeyer-Guignard J. Interferons and other regulatory cytokines. New York: John Wiley & Sons, 1988.
19. 19 Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25:1271-7.
20. 20 Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35:630-40.
21. 21 Cederblad B, Riesenfeld T, Alm GV. Deficient herpes simplex virus-induced interferon-alpha production by blood leukocytes of preterm and term newborn infants. Pediatr Res 1990; 27:7-10.
22. 22 Cederblad B, Alm GV. Interferons and the colony-stimulating factors IL-3 and GM-CSF enhance the IFN-alpha response in human blood leucocytes induced by herpes simplex virus. Scand J Immunol 1991; 34:549-55.
23. 23 Svensson H, Cederblad B, Lindahl M, Alm GV. Stimulation of natural interferon-α/β producing cells by Staphylococcus aureus. J Interferon Res 1996; 16:7-16.
24. 24 Cederblad B, Blomberg S, Vallin H, Perers A, Alm GV, Rönnblom L. Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-α producing cells. J Autoimmun 1998; 11:465-70..
25. 25 Cederblad B, Alm GV. Infrequent but efficient interferon-alpha-producing human mononuclear leukocytes induced by herpes simplex virus in vitro studied by immuno-plaque and limiting dilution assays. J Interferon Res 1990; 10:65-73.
26. 26 Gobl AE, Funa K, Alm GV. Different induction patterns of mRNA for IFN-alpha and -beta in human mononuclear leukocytes after in vitro stimulation with herpes simplex virus-infected fibroblasts and Sendai virus. J Immunol 1988; 140:3605-9.
27. 27 Sandberg K, Eloranta M-L, Campbell IL. Expression of alpha/beta interferons (IFN-α/β) and their relationship to IFN-α/β-induced genes in lymphocytic choriomeningitis. J Virol 1994; 68:7358-66.
28. 28 Svensson H, Johannisson A, Nikkilä T, Aim GV, Cederblad B. The cell surface phonotype of human natural interferon-α producing cells as determined by flow cytometry. Scand J Immunol 1996; 44:164-72.
29. 29 Zhou LJ, Schwarting R, Smith HM, Tedder TF. A novel cell-surface molecule expressed by human interdigitating reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily. J Immunol 1992; 149:735-42.
30. 30 al Janadi M, al Balla S, al Dalaan A, Raziuddin S. Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases. J Clin Immunol 1993; 13:58-67.
31. 31 Horwitz DA, Wang H, Gray JD. Cytokine gene profile in circulating blood mononuclcar cells from patients with systemic lupus erythematosus: increased interleukin-2 but not interleukin-4 mRNA. Lupus 1994; 3:423-8.
32. 32 Fitzgerald-Bocarsly P. Human natural interferon-α producing cells. Pharmac Ther 1993; 60:39-62.
33. 33 Artursson K, Lindersson M, Varela N, Scheynius A, Alm GV. Interferon-alpha production and tissue localization of interferon-alpha/beta producing cells after intradermal administration of Aujeszky's disease virus-infected cells in pigs. Scand J Immunol 1995; 41:121-9.
34. 34 Eloranta M-L, Sandberg K, Alm GV. The interferon-α/β responses of mice to herpes simplex virus studied at the blood and tissue level in vitro and vivo. Scand J Immunol 1996; 43:355-60.
35. 35 Pisetsky D. Immune activation by bacterial DNA. A new genetic code. Immunity 1996; 5:303-10.
36. 36 Krapf F, Herrmann M, Leitmann W, Kalden J. Antibody binding of macromolecular DNA and RNA in the plasma of SLE patients. Clin Exp Immunol 1989; 75:336-42.
37. 37 Sano H, Takai O, Harata N, Yoshinaga K, Kodama-Kamada I, Sasaki T. Binding properties of human anti-DNA antibodies to cloned human DNA fragments. Scand J Immunol 1989; 30:51-63.
38. 38 Miyata M, Kanno T, Ishida H et al. CpG motif in DNA from immune complexes of SLE patients augments expression of intercellular adhesion molecule-1 on endothelial cells. Jpn J Clin Pathol 1996, 44:1125-31.
39. 39 Krieg A. CpG, DNA: a pathogenic factor in systemic lupus erythematosus. J Clin Immunol 1995; 15:284-92.
40. 40 Strander H. Toxicities of interferons. In: Stuart-Harris R, Penny R, eds. Clinical applications of the interferons. London: Chapman & Hall, 1997:331-63.